Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-congenital-cardiac-malformations-following-armodafinil	Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis	Modular Programs	11/17/2020	Risk of Congenital Cardiac Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Modular Programs 11/17/2020
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016	Duration of Follow Up for New Molecular Entities Approved in 2016	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2016 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011	Duration of Follow Up for New Molecular Entities Approved in 2011	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2011 Analyses 04/16/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy	TreeScan in Pregnancy	Methods, Data, & Tools	07/14/2021	TreeScan in Pregnancy Methods, Data, & Tools 07/14/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017	Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis	Analyses	08/13/2021	Duration of Follow Up for New Molecular Entities Approved in 2017: A Descriptive Analysis Analyses 08/13/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/how-under-coded-pediatric-hypertension-comparison-claims-and	How Under-Coded is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data	Publications and Presentations	08/23/2021	How Under-Coded is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data Publications and Presentations 08/23/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/early-uptake-new-molecular-entities-approved-2017-multisite	Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network	Publications and Presentations	08/23/2021	Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network Publications and Presentations 08/23/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/longitudinal-trends-incident-and-prevalent-use-long-acting-beta-2	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis	Methods, Data, & Tools	08/24/2021	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis Methods, Data, & Tools 08/24/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/evaluation-existing-approaches-ehr-based-signal-identification	Evaluation of Existing Approaches to EHR-based Signal Identification	Methods, Data, & Tools	11/19/2021	Evaluation of Existing Approaches to EHR-based Signal Identification Methods, Data, & Tools 11/19/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/racial-differences-covid-19-outcomes-2020-2021	Racial Differences in COVID-19 Outcomes (2020-2021)	Assessments	12/08/2021	Racial Differences in COVID-19 Outcomes (2020-2021) Assessments 12/08/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-following	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis	Analyses	12/15/2021	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis Analyses 12/15/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-0	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis)	Analyses	12/15/2021	Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) Analyses 12/15/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-updated	Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis	Analyses	01/21/2022	Duration of Follow Up for New Molecular Entities Approved in 2017: An Updated Descriptive Analysis Analyses 01/21/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis	Analyses	01/26/2022	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Analyses 01/26/2022
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	03/24/2022	Quarterly Newsletter Spotlight 03/24/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/epidiolex-prescription-cannabidiol-utilization-patterns	Epidiolex (prescription cannabidiol) Utilization Patterns: A Descriptive Analysis	Analyses	03/28/2022	Epidiolex (prescription cannabidiol) Utilization Patterns: A Descriptive Analysis Analyses 03/28/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018	Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis	Analyses	04/20/2022	Duration of Follow Up for New Molecular Entities Approved in 2018: A Descriptive Analysis Analyses 04/20/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0	Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis	Analyses	04/25/2022	Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis Analyses 04/25/2022
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model	Sentinel Common Data Model	Methods, Data, & Tools	06/03/2022	Sentinel Common Data Model Methods, Data, & Tools 06/03/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis	Analyses	06/21/2022	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses 06/21/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/seizures-following-gadolinium-based-contrast-agents-exposure	Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis	Analyses	06/29/2022	Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis Analyses 06/29/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/fractures-following-leuprolide-acetate-use-multiple-factor	Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis (A Follow-up to a Previous Analysis)	Analyses	09/16/2022	Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis (A Follow-up to a Previous Analysis) Analyses 09/16/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-descriptive	Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis	Analyses	10/31/2022	Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis Analyses 10/31/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners	Onboarding of Commercial Electronic Health Record (EHR) Data Partners	Methods, Data, & Tools	11/01/2022	Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-signal	Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis	Analyses	11/10/2022	Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis Analyses 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis	Analyses	11/10/2022	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses 11/10/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-public-workshop	2022 14th Annual Sentinel Public Workshop	Sentinel Initiative Events	11/15/2022	2022 14th Annual Sentinel Public Workshop Sentinel Initiative Events 11/15/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment	Methods, Data, & Tools	12/09/2022	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools 12/09/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-innovation-and-methods-seminar-series	2023 Sentinel Innovation and Methods Seminar Series	Sentinel Initiative Events	01/01/2023	2023 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/comparative-risk-angioedema-sacubitril-valsartan-versus	Comparative Risk of Angioedema with Sacubitril-Valsartan Versus Renin-Angiotensin-Aldosterone Inhibitors	Publications and Presentations	01/24/2023	Comparative Risk of Angioedema with Sacubitril-Valsartan Versus Renin-Angiotensin-Aldosterone Inhibitors Publications and Presentations 01/24/2023
https://www.sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information	Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)	Methods, Data, & Tools	01/27/2023	Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2) Methods, Data, & Tools 01/27/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous-transluminal	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis	Analyses	02/09/2023	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis Analyses 02/09/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis	Analyses	02/09/2023	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis Analyses 02/09/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-updated-signal	Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis	Analyses	03/08/2023	Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis Analyses 03/08/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-select-biological-products-descriptive-analysis	Utilization of Select Biological Products: A Descriptive Analysis	Analyses	03/20/2023	Utilization of Select Biological Products: A Descriptive Analysis Analyses 03/20/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/healthverity-being-evaluated-fda-s-sentinel-initiative	HealthVerity Being Evaluated for FDA’s Sentinel Initiative	Sentinel Initiative Events	03/21/2023	HealthVerity Being Evaluated for FDA’s Sentinel Initiative Sentinel Initiative Events 03/21/2023